LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Profit Margin

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A (LFMDP) currently reports a profit margin of -0.9% as of June 2026. That compares with -2.88% in the prior-year period — up 68.9% year over year. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's profit margin history and peer comparisons.

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's profit margin increased from -2.88% to -0.9% — a 68.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's profit margin of -0.9% is lower than the Healthcare sector average of 21.34%. That is roughly 104.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's current -0.9% should be judged against Healthcare norms (sector average: 21.34%) and against LFMDP's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -0.9%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A, and consider following LFMDP for alerts when major investors trade the stock.